Clinicopathological Features of Inflammatory Myofibroblastic Tumor in the Breast. (12th August 2022)

• Record Type: Journal Article
• Authors: Liu, Shifei; Yuan, Rui; Jin, Yulan; He, Chunyan; Zheng, Xingzheng; Zhan, Yang
• Other Names: Hu Taobo Academic Editor.
• Is Part Of: Breast journal. Volume 2022(2022)
• Publication Date: 2022-08-12
• Subjects: Breast -- Diseases -- Periodicals; Breast -- Cancer -- Periodicals; 618.19
• DOI: 10.1155/2022/1863123
• Languages: English
• ISSNs: 1075-122X

Abstract

Abstract : Inflammatory myofibroblastic tumor (IMT) is a mesenchymal spindle cell tumour with low malignant potential which is extremely rare in breasts. Because of the lack of typical imaging and clinical characteristics of IMT, it is easy to misdiagnose before operation. We now report a case of a 37-year-old woman presenting with a mass in her left breast. Ultrasound showed a well-circumscribed lesion in the lower outer quadrant. The patient underwent lumpectomy, and histopathology revealed a tumor which was composed of fusiform cells and inflammatory cells. Immunohistochemistry (IHC) showed tumor cells are positive for vimentin, ALK, BCL2, and SMA. The FISH test demonstrated ALK (2p23) chromosomal translocation (ALK positive). The final diagnosis of breast IMT was rendered with nonclassical morphology. Postoperative 30-month follow-up no evidence showed residual tumor or recurrence. As a very rare tumor, breast IMT could be easily misdiagnosed clinically and pathologically. Complete surgical resection of the tumor is preferred, and it has the risk of recurrence and metastasis.